MEDICINES SELECTION & FORMULARY MANAGEMENT

Slides:



Advertisements
Similar presentations
Management of Drug Formulary Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 06/16/06.
Advertisements

Medication Management
Department of Medicines Policy and Standards The WHO Model List of Essential Medicines – Palliative Care update Suzanne Hill World Health Organisation.
Donald T. Simeon Caribbean Health Research Council
November 26, Fall Forum Alberta’s Pharmaceutical Strategy and Programs Policy Recommendations.
Differences in the availability of medicines used for chronic and acute conditions in developing countries Alexandra Cameron International Conference on.
“Rational Pharmacology” and Health Economics By Alan Maynard.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
Drug Utilization Review (DUR)
Hospital Pharmacy Payam Parchamazad, PharmD Staff Pharmacist
International Experience in Pharmaceutical Services for Promoting Access to Medicines: Canada, Cuba, England, Mexico International Seminar on the Challenges.
Pharmaceutical Services Unit Essential Medicines Management
Access to HIV/AIDS, Tuberculosis and Malaria Medicines. WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies. Geneva, 18 – 22 September.
Drug and Therapeutics Committee Session 7A. Identifying Problems with Medicine Use: Indicator Studies.
1 Drug and Therapeutics Committee Session 10. Standard Treatment Guidelines.
ZHRC/HTI Financial Management Training
Perspectives and achievements with Rational Pharmacotherapy Meeting under Danish EU presidency Implementation of Rational Pharmacotherapy Copenhagen, November.
1 Session 2. Developing and Maintaining a Formulary.
Entrenching the KNH Formulary to Clinical Practice DR WK SIGILAI MTC CHAIR.
Clinical Pharmacy Basma Y. Kentab MSc..
PERFORMANCE AUDIT REPORT ON MANAGEMENT OF PRIMARY HEALTH CARE (A CASE STUDY ON HEALTH CENTERS) 8/16/20151 Dr. Anna Nswilla CDHSMoHSW.
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
Pharmacy and Therapeutics Committee
Selection of essential medicines
Dr. Tahereh Safarnavadeh Clinical Pharmacist The Formulary Process In the Name of GOD.
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
Summary of ICIUM Chronic Care Track Prepared by: Ricardo Perez-Cuevas Veronika Wirtz David Beran.
Summary from the Economics Track With thanks to all track participants, presenters, rapporteurs, moderators and organizers.
Developing a Referral Management Plan. Background Hospital referral rates in England have increased significantly over recent years, resulting in the.
OVERVIEW OF THE ZIMBABWE NATIONAL MEDICINES POLICY Dr C E Ndhlovu, M Med Sci, FRCP Chairperson, NMTPAC Deputy Dean, UZCHS National workshop, Jan 22-23,
RHSC Meeting Kampala, May 2010 Quality for Medicines The Global Fund approach Sophie Logez Manager, QA and Data Quality Pharmaceutical Management.
Crosswalk of Public Health Accreditation and the Public Health Code of Ethics Highlighted items relate to the Water Supply case studied discussed in the.
ACCESS TO MEDICINES - POLICY AND ISSUES
ABSTRACT Title: Developing National Formularies Based on the WHO Model Formulary Authors: Tisocki K 3, Laing RL 1, Hogerzeil H 1, Mehta DK 2, Ryan RSM.
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Promoting Drug and Therapeutics Committees in the Developing World
Yemaneberhan Taddesse.  PASDEP(plan of accelerated and sustainable development for the Eradication of poverty) Poverty reduction strategy is the main.
Abstract ID: 395 Author Name: Araya Sripairoj Presenter Name: Araya Sripairoj Authors: Sripairoj A, Liamputtong P, Harvey K.
Determinants of Rational Use of Medicines Dr A K Sharma Prof & Head Dept of Pharmacology AFMC, Pune.
Medication Error Reduction Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
“USAPI-PHARMACY ASSOCIATION - RESPONSE TO NCD ROADMAP” Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa 51 st 1-18 nov 2011 Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa.
COMPARATIVE ANALYSIS OF SELECTED ESSENTIAL DRUG LISTS AZIZ JAFAROV/RICHARD LAING.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
HEALTH FINANCING MOH - HPG JAHR UPDATE ON POLICIES Eleventh Party Congress -Increase state investment while simultaneously mobilizing social mobilization.
MEDICATION MANAGEMENT P&T COMMITTEE AND FORMULARY MANAGEMENT EMTENAN ALHARBI, Msc CLINICAL PHARMACIST.
Selection of essential medicines Richard Laing and Deidre Dimancesco TBS 2011 Department of Essential Medicines & Pharmaceutical Policies TBS 2008.
TBS Meeting Geneva, November 2010 Procurement and Supply Management Policies WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November.
EVALUATION OF TYPE C HOSPITAL FORMULARY IN YOGYAKARTA
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
DEVELOPING NATIONAL FORMULARIES BASED ON THE WHO MODEL FORMULARY Tisocki K, Laing RL, Hogerzeil H, Mehta DK, Ryan RSM.
Drug Formulary Development & Management
Managed Care Career Path for Student Pharmacists Presentation Developed for the Academy of Managed Care Pharmacy Updated February 2015.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Documentation in Practice Dept. of Clinical Pharmacy.
Ghada Aboheimed, Msc. Review the principles of an evidence based approach to clinical practice. Appreciate the value of EBM Describe the 5 steps of evidence.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Pharmacy & Therapeutics Committee Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2016.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Pharmacy & Therapeutics Committee
WHO Medicines Work in Countries: The Kenya Example
Introduction to Clinical Pharmacy
Pharmacy & Therapeutics Committee
Primum non nocere Olabisi Oshikanlu M.D., F.A.A.P
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Session 2. Developing and Maintaining a Formulary
Standard Treatments.
Access to Essential Medicines
Pharmacy & Therapeutics Committee
Pharmacy & Therapeutics Committee
Presentation transcript:

MEDICINES SELECTION & FORMULARY MANAGEMENT Charles Ouma Management Sciences for Health

Outline Essential Medicines Concept Formulary system Key definitions Interrelationships- STGs, EML, Formulary Manual Formulary Management Principles Challenges and opportunities

Issues and Complexities with Medicine Use (1) Numerous medicinal products are available in the world Several therapeutic groups and medicines are available to treat many diseases New medicinal products and new information about existing medicines are emerging

Issues and Complexities with Medicine Use (2) Developing countries spend up to 40% of their health care budgets on medicines An estimated 70% of medicines are considered duplicative or non-essential Lack of access to medicines is a major and chronic issue in resource-constrained settings In low- and middle-income countries, most people pay for medicines out-of-pocket Source: Management Sciences for Health. 2012. MDS-3: Managing Access to Medicines and Health Technologies. Arlington, VA: Management Sciences for Health. http://www.msh.org/resource-center/publications/upload/MDS3-Ch16-Selection-Mar2012.pdf

Essential Medicines Concept Select & use “essential medicines” that- Satisfy the priority health care needs of the population Selected with due regard to public health relevance, evidence on efficacy and safety, and comparative cost-effectiveness Intended to be available within the context of functioning health systems at all times in adequate amounts, in the appropriate dosage forms, with assured quality and adequate information and at a cost that individuals and the community can afford

Formulary System and Management

Key Definitions Formulary—A list of medicines approved for use in the healthcare system by authorized prescribers Formulary manual—The document that describes medicines that are available for use in a hospital or clinic (i.e., indications, dosage, length of treatment, interactions, precautions, and contraindications) Formulary system—A system of periodically evaluating and selecting medicines for the formulary, maintaining the formulary, and providing information in a suitable manual or list

Interrelationships- STGs, EML & Essential Medicines Formulary

Benefits of an Effective Formulary System—Summary Prescribing More experience with fewer medicines Irrational alternatives not available Focused medicine information ADRs easier to manage Cost Lower prices, more competition Supply Easier procurement Lower amount of stocks Improved quality assurance Easier dispensing Patient Use Focused education efforts Better compliance Improved availability

Steps to Add or Delete a New Medicine Written request DTC Secretary Drug literature evaluation Written report; formulary recommendations DTC Meeting Request approved/rejected Information disseminated Physician or pharmacist Transparent decision making MTC Secretariat MTC Healthcare Workers

Process- Selection & Formulary Changes Health Care workers Submission of motivations or requests Use formulary for procurement and Patient Management MTC Secretariat Receipt and processing of motivation Transparency, fairness, feedback to ‘motivators’ MTC Secretariat Technical Evaluation of motivation Compilation of summary document for presentation to MTC or Formulary sub- committee MTC or Formulary sub-committee Discussion of motivations based on evidence Composition of committee Timely decision making Communication of decisions to motivators Dissemination of approved changes to HCWs Printing and distribution of new Formulary Key success factors

Formulary Management Principles (1) Select medicines on the basis of need (diseases and conditions that have been identified locally) Select “medicines of choice” Avoid duplications and use INN (generic) names Use combination (fixed-dose) products only in specific proven conditions (e.g., TB)

Formulary Management Principles (2) Evaluate and select new medicines according to agreed-upon explicit criteria (including efficacy, safety, quality, cost) Ensure consistency between the formulary list and the recommended standard treatment guidelines Regularly review and update the formulary Monitor and control the use of non-formulary medicines Restrict medicines to use by appropriate practitioners

Formulary Management Principles (3) Maintain reliable resources (human, financial, references) for evaluating medicines Keep the formulary process ethically correct and transparent Enlist support of key policy makers and influential health professionals to advocate for the MTC and the formulary system

Challenges Weak (formulary) management systems Relentless push by HCWs for inclusion of new, costly agents without considering formulary management principles Weak (formulary) management systems Lack of comprehensive treatment guidelines Ad-hoc requests for changes & non-involvement of all stakeholders Lack of comprehensive guidelines for submitting requests & evaluating motivations/evaluations Issues of transparency

Challenges (2) Lack of resources and or expertise to conduct evaluations and or pharmacoeconomic analyses at institutional/ local setting to provide cost-effectiveness data that is more relevant to the local setting Non integration of medicine selection with guidelines and formulary development

Formulary Management: Success Factors Robust compliance environment is required to operationalize a formulary system procurement and use of essential medicines should be guided by the formulary MTC comprising multi-disciplinary health workers that is responsible for reviewing applications for changes An active body at the hospital responsible for coordinating the formulary management process (MTC secretariat) High level institutional leadership and/or support for the formulary process Transparency and feedback

Results — What should be measured What are the expected results Improved outcomes Standardization of care Most effective treatments prescribed Improved procurement and supply Forecast compares with utilization Efficient use of funds

Thank you